Company news
Aclarion, Inc. news in 2025
Aclarion, Inc.'s news releases, calls and decks from 2025, newest first.
Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS)
December 4, 2025
Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.
December 2, 2025
Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion
November 5, 2025
Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
October 22, 2025
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst
October 14, 2025
Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference
October 13, 2025
Aclarion to Present at the LD Micro Main Event XIX
October 9, 2025
Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
October 7, 2025
Aclarion Presents at LSI Europe ’25 Highlighting Nociscan Technology and Key Value Drivers
October 1, 2025
First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial
September 25, 2025
Aclarion Appoints Greg Gould as Chief Financial Officer
September 3, 2025
Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts
August 5, 2025
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders
July 7, 2025
First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
June 25, 2025
Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum
June 24, 2025
Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site
June 10, 2025
Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site
May 20, 2025
Aclarion Announces Texas Back Institute as New CLARITY Trial Site
May 12, 2025
Aclarion Welcomes Advocate Health as CLARITY Trial Site
May 5, 2025
Aclarion Announces Commercial Agreement with Spine Institute of Louisiana
April 29, 2025
Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025
April 23, 2025
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis
April 21, 2025
Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub
April 9, 2025
Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California
April 2, 2025
Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives
March 31, 2025
Aclarion Announces Reverse Stock Split
March 26, 2025
Aclarion Provides Shareholder Update
March 13, 2025
Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey
March 6, 2025
Aclarion Announces First Commercial Agreement with Scripps Health
March 3, 2025
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
February 28, 2025
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit
February 20, 2025
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body
February 10, 2025
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
February 5, 2025
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded
February 3, 2025
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference
January 30, 2025
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market
January 29, 2025
Aclarion Announces Revised Split Ratio and Timing for Reverse Stock Split
January 27, 2025
Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants
January 16, 2025
Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants
January 14, 2025
Decks in 2025
- Investor Presentation (April 2025)
Investor deck · 22 slides · Apr 23, 2025